Meridian Clinical Trials Paul-TanPiengco

Venkat brings a very rich and global experience of more than 25 years, successfully leading organizations in the biotech and cosmeceutics businesses. He held top management roles in biotech and pharmaceutical companies like ShanthaBiotechnics (A Sanofi Company) and Aurobindo Pharma, roles in which he immensely contributed to the Companies’ all-round growth. He was instrumental in creating market focus and orchestrating vaccine portfolio strategy in Shantha Biotech, a biosimilar and vaccine company, which was eventually acquired by Sanofi for $800 million. He has been a part of significant revenue growth and value creation in Aurobindo Pharma in the global business segment of APIs and finished dosage form products in multiple therapy areas.

Speaker Details
Events of the Speaker
You might also love these events.
November 22, 2021
Lorem ipsum dolor sit amet, voluptua iracundia an pri, his utinam principes dignissim ad. Ne nec dolore oblique nusquam, cu luptatum volutpat delicatissimi has.